These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 19682127)

  • 1. Plasma carboxymethyl-lysine, an advanced glycation end product, and all-cause and cardiovascular disease mortality in older community-dwelling adults.
    Semba RD; Bandinelli S; Sun K; Guralnik JM; Ferrucci L
    J Am Geriatr Soc; 2009 Oct; 57(10):1874-80. PubMed ID: 19682127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum carboxymethyl-lysine, an advanced glycation end product, is associated with arterial stiffness in older adults.
    Semba RD; Sun K; Schwartz AV; Varadhan R; Harris TB; Satterfield S; Garcia M; Ferrucci L; Newman AB;
    J Hypertens; 2015 Apr; 33(4):797-803; discussion 803. PubMed ID: 25915884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced glycation end products and their circulating receptors predict cardiovascular disease mortality in older community-dwelling women.
    Semba RD; Ferrucci L; Sun K; Beck J; Dalal M; Varadhan R; Walston J; Guralnik JM; Fried LP
    Aging Clin Exp Res; 2009 Apr; 21(2):182-90. PubMed ID: 19448391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced glycation/glycoxidation endproduct carboxymethyl-lysine and incidence of coronary heart disease and stroke in older adults.
    Kizer JR; Benkeser D; Arnold AM; Ix JH; Mukamal KJ; Djousse L; Tracy RP; Siscovick DS; Psaty BM; Zieman SJ
    Atherosclerosis; 2014 Jul; 235(1):116-21. PubMed ID: 24825341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carboxymethyl-lysine, an advanced glycation end product, and decline of renal function in older community-dwelling adults.
    Semba RD; Fink JC; Sun K; Bandinelli S; Guralnik JM; Ferrucci L
    Eur J Nutr; 2009 Feb; 48(1):38-44. PubMed ID: 19031098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating selenium and carboxymethyl-lysine, an advanced glycation endproduct, are independent predictors of anemia in older community-dwelling adults.
    Roy CN; Semba RD; Sun K; Bandinelli S; Varadhan R; Patel KV; Guralnik JM; Ferrucci L
    Nutrition; 2012 Jul; 28(7-8):762-6. PubMed ID: 22325035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of an advanced glycation end product, plasma carboxymethyl-lysine, with slow walking speed in older adults: the InCHIANTI study.
    Semba RD; Bandinelli S; Sun K; Guralnik JM; Ferrucci L
    Eur J Appl Physiol; 2010 Jan; 108(1):191-5. PubMed ID: 19756703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum carboxymethyl-lysine, an advanced glycation end product, is associated with increased aortic pulse wave velocity in adults.
    Semba RD; Najjar SS; Sun K; Lakatta EG; Ferrucci L
    Am J Hypertens; 2009 Jan; 22(1):74-9. PubMed ID: 19023277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma klotho and cardiovascular disease in adults.
    Semba RD; Cappola AR; Sun K; Bandinelli S; Dalal M; Crasto C; Guralnik JM; Ferrucci L
    J Am Geriatr Soc; 2011 Sep; 59(9):1596-601. PubMed ID: 21883107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of a dominant advanced glycation end product, serum carboxymethyl-lysine, and abnormal glucose metabolism in adults: the Baltimore Longitudinal Study of Aging.
    Semba RD; Beck J; Sun K; Egan JM; Carlson OD; Varadhan R; Ferrucci L
    J Nutr Health Aging; 2010 Aug; 14(7):507-13. PubMed ID: 20818463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced Glycation End Products, Oxidation Products, and Incident Cardiovascular Events in Patients With Type 2 Diabetes.
    Koska J; Saremi A; Howell S; Bahn G; De Courten B; Ginsberg H; Beisswenger PJ; Reaven PD;
    Diabetes Care; 2018 Mar; 41(3):570-576. PubMed ID: 29208654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carboxymethyl lysine, an advanced glycation end product, and incident diabetes: a case-cohort analysis of the ARIC Study.
    Luft VC; Duncan BB; Schmidt MI; Chambless LE; Pankow JS; Hoogeveen RC; Couper DJ; Heiss G
    Diabet Med; 2016 Oct; 33(10):1392-8. PubMed ID: 26359784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum and Tissue Levels of Advanced Glycation End Products and Risk of Mortality in Patients on Maintenance Hemodialysis.
    Jiang J; Zhang Y; Chen J; Yang X; Mei C; Xiong F; Shi W; Zhou W; Liu X; Sun S; Zhang P; Zhang Y; Zhang Y; Liu S; Zhang Z; Lin Q; Yu Y; Tian J; Luo W; Qin X; Hou FF
    Am J Nephrol; 2021; 52(1):8-16. PubMed ID: 33596571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary Intake of Nε-carboxymethyl-lysine, a Major Advanced Glycation End Product, is Not Associated with Increased Risk of Mortality in Japanese Adults in the Takayama Study.
    Nagata C; Wada K; Yamakawa M; Nakashima Y; Koda S; Uji T; Oba S
    J Nutr; 2020 Oct; 150(10):2799-2805. PubMed ID: 32840609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum carboxymethyl-lysine, a dominant advanced glycation end product, is associated with chronic kidney disease: the Baltimore longitudinal study of aging.
    Semba RD; Fink JC; Sun K; Windham BG; Ferrucci L
    J Ren Nutr; 2010 Mar; 20(2):74-81. PubMed ID: 19853477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating Advanced Glycation Endproducts and Long-Term Risk of Cardiovascular Mortality in Kidney Transplant Recipients.
    Sotomayor CG; Gomes-Neto AW; van Londen M; Gans ROB; Nolte IM; Berger SP; Navis GJ; Rodrigo R; Leuvenink HGD; Schalkwijk CG; Bakker SJL
    Clin J Am Soc Nephrol; 2019 Oct; 14(10):1512-1520. PubMed ID: 31530552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Higher plasma levels of advanced glycation end products are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12-year follow-up study.
    Nin JW; Jorsal A; Ferreira I; Schalkwijk CG; Prins MH; Parving HH; Tarnow L; Rossing P; Stehouwer CD
    Diabetes Care; 2011 Feb; 34(2):442-7. PubMed ID: 21270199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary excretion of amino acids and their advanced glycation end-products (AGEs) in adult kidney transplant recipients with emphasis on lysine: furosine excretion is associated with cardiovascular and all-cause mortality.
    Baskal S; Post A; Kremer D; Bollenbach A; Bakker SJL; Tsikas D
    Amino Acids; 2021 Nov; 53(11):1679-1693. PubMed ID: 34693489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advanced glycation end product carboxymethyl-lysine and risk of incident peripheral artery disease in older adults: The Cardiovascular Health Study.
    Garg PK; Biggs ML; Barzilay J; Djousse L; Hirsch C; Ix JH; Kizer JR; Tracy RP; Newman AB; Siscovick DS; Mukamal KJ
    Diab Vasc Dis Res; 2019 Sep; 16(5):483-485. PubMed ID: 31064218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fat mass is inversely associated with serum carboxymethyl-lysine, an advanced glycation end product, in adults.
    Semba RD; Arab L; Sun K; Nicklett EJ; Ferrucci L
    J Nutr; 2011 Sep; 141(9):1726-30. PubMed ID: 21775524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.